A therapeutic HPV vaccine could eliminate precancerous cervical lesions, clinical trial suggests
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase II clinical trial published in Clinical Cancer Research.
Jan 24, 2025
0
0